RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Forcing Bioasis to AnswerAnd before anyone highlights to me the benefits we are receiving as a Biodexa shareholder, yeah, it is not lost on me that we will be getting Midatech assets. And I’m sure they have a swell pipeline with wonderful assets, but they are already a Nasdaq listed company and as broke or more broke than we are.
This whole concept of combing two wrongs to make a right seems rather clown world to me.
Furthermore, I am a Biosis investor because I was enamored with XB3 and the hope of getting drugs elegantly across the BBB to treat serious and debilitating CNS diseases. I am not however interested in implanting pumps into children’s abdomens with catheters traversing to thier brain delivering toxic chemotherapy directly a tumor. Calling these companies synergistic could be perhaps the biggest laugher of all. Wouldn’t XB3 if it worked negate the needs for brute force drug delivery with mechanical pumps and neurosurgically implanted catheters? Sorry, this is not cutting edge or revolutionary or anything like what I signed up to invest in when I bought Biosis shares….